Aspect Biosystems is a privately held biotechnology company pioneering microfluidic 3D bioprinting of living, human tissue. The company’s proprietary technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to enable the creation of living, human tissues for medical research, therapeutic discovery, and regenerative medicine products.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
3D printed meniscus tissue implant, 3D printed pancreatic patch for Type 1 Diabetes
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):